Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/19/2008EP1713804B1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
03/19/2008EP1711174B1 Adjuvant compositions
03/19/2008EP1696905B1 Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
03/19/2008EP1691813B1 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals;
03/19/2008EP1682122B1 Combinations of valsartan, amiloride or triamterine, and a diuretic
03/19/2008EP1660487B1 Pyrrole compositions useful as inhibitors of c-met
03/19/2008EP1654241B1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
03/19/2008EP1646613B1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
03/19/2008EP1638966B1 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO ¬3,4-d PYRIMIDINE AND USES THEREOF
03/19/2008EP1636223B1 Benzothiazole derivatives as adenosine receptor ligands
03/19/2008EP1628979B1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
03/19/2008EP1581210B1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
03/19/2008EP1575577A4 Composition for the prevention and treatment of inflammation of the ear
03/19/2008EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
03/19/2008EP1532132B1 Novel benzodioxoles
03/19/2008EP1532130A4 Process for the production of an immunosuppressant
03/19/2008EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
03/19/2008EP1511751B1 Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents
03/19/2008EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists
03/19/2008EP1496876B1 Aerosol formulation for inhalation comprising tiotropiumbromide
03/19/2008EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects
03/19/2008EP1469848B1 Sedative non-benzodiazepine formulations
03/19/2008EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors
03/19/2008EP1453487B1 Pharmaceutical dosage form with multiple coatings
03/19/2008EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS
03/19/2008EP1438964B1 Process for producing collagen production enhancers and use thereof
03/19/2008EP1432715B1 Pyrimidine derivatives
03/19/2008EP1429725B1 Ophthalmic depot formulations for periocular or subconjunctival administration
03/19/2008EP1414453B1 Fexofenadine hydrochloride polymorph
03/19/2008EP1399450B1 Benzoxazepine derivatives and their use as ampa receptor stimulators
03/19/2008EP1392271B1 Swallow tablet comprising paracetamol
03/19/2008EP1383556B9 INJECTION DEVICE FOR ADMINISTERING mRNA
03/19/2008EP1363630B1 Kappa opioid receptor ligands
03/19/2008EP1362031B1 Pharmaceutically active piperidine derivatives
03/19/2008EP1353668B1 Processes for the preparation of pharmaceutical preparations containing epothilone analogues for the treatment of cancer
03/19/2008EP1307423B1 Processes for the production of fexofenadine
03/19/2008EP1303496B9 Pyrimidine derivatives
03/19/2008EP1300141B1 Medical composition kit for treating lesioned abnormal tissue
03/19/2008EP1296970B1 Method for the preparation of citalopram
03/19/2008EP1283711B1 Peptide deformylase inhibitors
03/19/2008EP1280604B1 Media milling
03/19/2008EP1196083B1 Imaging the dopamine transporter to determine ad-hd
03/19/2008EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/19/2008EP1085877B1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
03/19/2008EP1043328B1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof
03/19/2008EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
03/19/2008EP1019033B1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide
03/19/2008EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/19/2008EP0980240B1 Sustained-release compositions and method for preparing same
03/19/2008EP0971735B1 Methods and compositions for treating inflammatory bowel disease
03/19/2008EP0920527B1 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
03/19/2008CN101146817A Novel compounds derived from 5-thioxylose and therapeutic use thereof
03/19/2008CN101146816A Glycolipids of branched chain alkyl oligosaccharides for liquid crystal and related applications
03/19/2008CN101146811A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/19/2008CN101146809A Process for preparing quinoline compounds and products obtained therefrom
03/19/2008CN101146808A Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
03/19/2008CN101146806A Pyrazole derivatives for the inhibition of CDK and GSK
03/19/2008CN101146805A Production method for thiazolidinedione compound and its production intermediate
03/19/2008CN101146804A 5-(1,3-diaryl-1h-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent
03/19/2008CN101146803A Pyrrolidine inhibitors of IAP
03/19/2008CN101146802A Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor
03/19/2008CN101146801A New salt and polymorphs of a dpp-iv inhibitor
03/19/2008CN101146800A Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
03/19/2008CN101146798A Novel heterocyclic benzo[C]chromene derivatives useful as modulators of the estrogen receptors
03/19/2008CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
03/19/2008CN101146795A Pyrazole derivatives for the inhibition of CDK and GSK
03/19/2008CN101146794A Pyrazole derivatives for the inhibition of CDK and GSK
03/19/2008CN101146793A Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
03/19/2008CN101146791A 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors
03/19/2008CN101146790A 2-okso-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidiner anvendt som cgrp-antagonister
03/19/2008CN101146789A Chemical compounds
03/19/2008CN101146787A Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia
03/19/2008CN101146782A Metasubstituted thiazolidinones, their manufacture and use as a drug
03/19/2008CN101146781A Spirocyclic thrombin receptor antagonists
03/19/2008CN101146780A New 3-aryl-1,2-benzisoxazole compounds are heat shock protein 90 inhibitors, useful to treat solid or liquid cancer, preferably cancers resistant to cytotoxic agents
03/19/2008CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases
03/19/2008CN101146775A Metabolites for nk-i antagonists for emesis
03/19/2008CN101146774A Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
03/19/2008CN101146771A Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic acid derivatives
03/19/2008CN101146770A 2-phenyl-indoles as prostaglandin D2 receptor antagonists
03/19/2008CN101146767A Taurine synthesis, production and utility as a medicine
03/19/2008CN101146766A Acyl hydrazides as kinase inhibitors, in particular for SGK
03/19/2008CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics
03/19/2008CN101146764A Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
03/19/2008CN101146763A Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/19/2008CN101146575A New class of gamma delta T cells activators and use thereof
03/19/2008CN101146549A Antiangiogenic agents and aldesleukin
03/19/2008CN101146548A Methods for treating lymphomas using a combination of a chemotherapeutic agent and IL-2 and optionally an anti-CD20 antibody
03/19/2008CN101146542A Risedronate compositions and their methods of use
03/19/2008CN101146541A Method and composition for treating central nervous system disorders
03/19/2008CN101146540A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/19/2008CN101146539A Use of pde7 inhibitors for the treatment of neuropathic pain
03/19/2008CN101146538A Treatment of metastasized tumors
03/19/2008CN101146537A Therapeutic agent for thrombosis
03/19/2008CN101146536A Drug delivery systems for treatment of diseases or conditions
03/19/2008CN101146535A Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
03/19/2008CN101146534A Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use
03/19/2008CN101146533A Combinations of pyrazole kinase inhibitors and further antitumor agents
03/19/2008CN101146532A Pharmaceutical compounds
03/19/2008CN101146531A Pharmaceutical compounds
1 ... 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 ... 7860